microarray processing analysis (Thermo Fisher)
Structured Review
Microarray Processing Analysis, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+processing+and+analysis/pm35077654-102-1-0
Average 90 stars, based on 1 article reviews
Images
Related Articles
Microarray:Article Title: In vivo gene expression profile of guided bone regeneration associated with a microrough titanium surface. Article Snippet: Objectives: To determine the gene expression profile characteristic of ‘‘guided bone regeneration’’ associated with a microrough titanium surface.. Material and methods: Critical-size calvarial defects were treated with the principle of ‘‘guided bone regeneration,’’ whereby the extracranial barriers were either polished (SMO) or microrough (SLA) titanium disks.. After 7 and 14 days, the contents of the regenerating defect were collected, RNA was extracted and microarray analysis was carried out. Article Title: Therapeutic potential of MEK inhibition in acute myelogenous leukemia: rationale for "vertical" and "lateral" combination strategies. Article Snippet: In hematological malignancies, constitutive activation of the RAF/MEK/ERK pathway is frequently observed, conveys a poor prognosis, and constitutes a promising target for therapeutic intervention.. Here, we investigated the molecular and functional effects of pharmacological MEK inhibition in cell line models of acute myeloid leukemia (AML) and freshly isolated primary AML samples.. The small-molecule, ATP-non-competitive, MEK inhibitor PD0325901 markedly inhibited ERK phosphorylation and growth of several AML cell lines and approximately 70 % of primary AML samples. Article Title: CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression. Article Snippet: The antibody against caspase-3 was commercially obtained from Cell Signaling Technologies (Beverly, MA, USA; catalog no. 9251). .. The protocol used for the sample preparation and Article Title: Differentially expressed genes in preimplantation human embryos: potential candidate genes for blastocyst formation and implantation Article Snippet: Arrays were scanned with the Affymetrix scanner (model 3000) with 7G upgrade, and data were collected using the GeneChip operating software (GCOS v3.1). .. CEL file output from Article Title: A non-conserved miRNA regulates lysosomal function and impacts on a human lysosomal storage disorder. Article Snippet: .. Article Title: Type I IFNs Regulate Inflammation, Vasculopathy, and Fibrosis in Chronic Cutaneous Graft-versus-Host Disease. Article Snippet: .. Affymetrix (Santa Clara, CA) GeneChip Mouse Genome 430 2.0 Article Title: CTGF Associated with Oncogenic Activities and Drug Resistance in Glioblastoma Multiforme (GBM) Article Snippet: Microarray procedures Vector control GBM cells (U343-V) and CTGF stably transfected cells (U343-CTGF: A combination of 50% U343-CTFG-1 and 50% U343-CTGF-2) were harvested and total RNA was extracted using RNeasy purification kit (Qiagen Inc., Valencia, CA) following the manufacturer’s advice. .. The detailed protocol for the sample preparation and Sample Prep:Article Title: In vivo gene expression profile of guided bone regeneration associated with a microrough titanium surface. Article Snippet: Objectives: To determine the gene expression profile characteristic of ‘‘guided bone regeneration’’ associated with a microrough titanium surface.. Material and methods: Critical-size calvarial defects were treated with the principle of ‘‘guided bone regeneration,’’ whereby the extracranial barriers were either polished (SMO) or microrough (SLA) titanium disks.. After 7 and 14 days, the contents of the regenerating defect were collected, RNA was extracted and microarray analysis was carried out. Article Title: Therapeutic potential of MEK inhibition in acute myelogenous leukemia: rationale for "vertical" and "lateral" combination strategies. Article Snippet: In hematological malignancies, constitutive activation of the RAF/MEK/ERK pathway is frequently observed, conveys a poor prognosis, and constitutes a promising target for therapeutic intervention.. Here, we investigated the molecular and functional effects of pharmacological MEK inhibition in cell line models of acute myeloid leukemia (AML) and freshly isolated primary AML samples.. The small-molecule, ATP-non-competitive, MEK inhibitor PD0325901 markedly inhibited ERK phosphorylation and growth of several AML cell lines and approximately 70 % of primary AML samples. Article Title: CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression. Article Snippet: The antibody against caspase-3 was commercially obtained from Cell Signaling Technologies (Beverly, MA, USA; catalog no. 9251). .. The protocol used for the sample preparation and Article Title: CTGF Associated with Oncogenic Activities and Drug Resistance in Glioblastoma Multiforme (GBM) Article Snippet: Microarray procedures Vector control GBM cells (U343-V) and CTGF stably transfected cells (U343-CTGF: A combination of 50% U343-CTFG-1 and 50% U343-CTGF-2) were harvested and total RNA was extracted using RNeasy purification kit (Qiagen Inc., Valencia, CA) following the manufacturer’s advice. .. The detailed protocol for the sample preparation and other:Article Title: Comparative study of the transcriptomes of Caco-2 cells cultured under dynamic vs. static conditions following exposure to titanium dioxide and zinc oxide nanomaterials. Article Snippet: Expressing:Article Title: Differentially expressed genes in preimplantation human embryos: potential candidate genes for blastocyst formation and implantation Article Snippet: Arrays were scanned with the Affymetrix scanner (model 3000) with 7G upgrade, and data were collected using the GeneChip operating software (GCOS v3.1). .. CEL file output from |
